Related Experiment Video
Updated: Apr 30, 2026
06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
1.6K
Rabbit MSTN gene polymorphisms and genetic effect analysis
1College of Animal Science and Technology, Shandong Agricultural University, Tai'an, China.
Genetics and Molecular Research : GMR
|May 1, 2014
Summary
A novel mutation in the myostatin (MSTN) gene's regulatory region was identified in rabbits. This genetic variation positively impacts meat quality and carcass traits, offering potential for selective breeding.
Area of Science:
- Animal Genetics
- Molecular Biology
- Meat Science
Background:
- The myostatin (MSTN) gene plays a crucial role in regulating muscle growth.
- Understanding genetic variations in MSTN is important for improving livestock traits.
- Rabbit meat quality is influenced by genetic factors.
Purpose of the Study:
- To investigate genetic polymorphisms in the myostatin (MSTN) gene in rabbits.
- To identify mutations within the exon and regulatory regions of the MSTN gene.
- To assess the impact of identified mutations on rabbit meat quality and carcass characteristics.
Main Methods:
- Sequencing and single-strand conformation polymorphism (SSCP) techniques were employed.
- Analysis covered three exon regions and a portion of the 5'-regulatory region of the MSTN gene.
- Correlation analysis was performed to link genetic mutations with phenotypic traits.
Main Results:
- A single nucleotide mutation (T→C) was detected at the 476 locus in the 5'-regulatory region of the MSTN gene.
- No mutation sites were found within the exon regions of the MSTN gene.
- The identified mutation was associated with favorable genetic effects, including increased carcass and organ weights, and reduced meat loss.
Conclusions:
- Mutations in the upstream regulatory region of the MSTN gene benefit rabbit somatic development.
- The identified MSTN gene mutation serves as a valuable molecular marker for enhancing rabbit meat quality.
- This finding supports the use of molecular markers in selective breeding programs for rabbits.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
01:27Principles of Pharmacogenetics: Types of Genetic Variants
138
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138
01:05Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
01:27Pharmacogenetics of Drug Metabolism: Overview
194
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
194
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
189
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189